• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Hyderus

Hyderus Cyf and Hyderus Teoranta

Pandemicast
  • Home
  • Tell the Truth
    • Videos
  • About us
    • Access to innovative medicines
    • New Work in India
    • Mark Chataway
    • We pay our taxes
    • Our approach to managing risk perception and crises
    • African journalists we respect
  • Customers
  • Expertise
    • Development and Politics
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      • Drivers and barriers for new vaccines
    • Strategic Planning
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Contact
  • Blog
    • What we’re thinking
    • Our World
    • Staff blog
  • Flexible Pricing Plan

Global Health Progress

Five myths about access to medicines in emerging markets

July 22, 2015 by Mark Chataway 1 Comment

Pharma companies can have an “emerging markets strategy”   Emerging markets are nothing like one another: an Argentinian denied an expensive new drug will usually just go and get a court to order his insurer or the state to pay for it; an Indonesian may never even find out what’s wrong with him.  Argentina spends about $1050 per person on … [Read more...] about Five myths about access to medicines in emerging markets

Filed Under: Our craft Tagged With: access to medicines, Global Health Progress, health policy, pharmaceutical industry

The failure of global health advocacy spelled out in numbers

July 11, 2015 by Mark Chataway Leave a Comment

No fashionable university is without its own department doing studies and advocacy on global health these days and NGOs and consultancies proliferate. Richard Horton and his team at The Lancet seem to produce ever more elaborate reports and commissions demanding an extra $30 billion here or $50 billion there. None of them tell you that funding for … [Read more...] about The failure of global health advocacy spelled out in numbers

Filed Under: Featured Tagged With: advocacy, Global Health Progress, health policy, public health

International declarations and treaties don’t change things — Tweets do

July 10, 2015 by Mark Chataway 1 Comment

There was a time when international declarations changed the world. Maybe some still do but increasingly leaders communicate in 140 characters, not 20-page communiqués. Even international agreements and treaties may not be worth the paper they're written on, much less the thousands of days of staff time that go into them, according to an elegant … [Read more...] about International declarations and treaties don’t change things — Tweets do

Filed Under: Featured Tagged With: Africa, Global Health Progress, health policy, international treaties

#Indonesia #universalhealth plan seems destined for failure – BBC documentary

November 11, 2013 by Mark Chataway Leave a Comment

The BBC World Service this week ran a 30-minute in-depth examination of Indonesia's alarmingly vague plans for a universal healthcare service. Following the BBC's fashion for human interest, the programme is heavy on disconnected individual stories and light on heavy analysis. Indonesia's health minister, Dr Nafsiah Mboi, must have been relieved … [Read more...] about #Indonesia #universalhealth plan seems destined for failure – BBC documentary

Filed Under: Featured Tagged With: Global Health Progress, Indonesia, public health, universal healthcare

As concerns over governance grow, Clinton Foundation shifts focus to women and children

August 17, 2013 by Mark Chataway Leave a Comment

The New York Times reports unease at the stable of charities and companies centred around former President Bill Clinton.  The unease stems in part from the former President's freewheeling and informal style; part from the influence of a few close aides and; in part because Chelsea, Clinton's daughter, worries that the Foundation will die with him. … [Read more...] about As concerns over governance grow, Clinton Foundation shifts focus to women and children

Filed Under: Featured Tagged With: Clinton, Global Health Progress, health policy

BRICS co-operation on health: where’s the beef?

July 8, 2013 by Mark Chataway Leave a Comment

The Bullet of the World Health Organization has issued a call for papers for a themed issue on "BRICS and global health to enhance people’s understanding of the dynamics of health and development in BRICS countries and of how these countries contribute to global health, both by improving health outcomes in their own territories and by engaging in … [Read more...] about BRICS co-operation on health: where’s the beef?

Filed Under: Featured Tagged With: Development, Global Health Progress, health, ODA, WHO

Pharmas intimacy problem with social media

July 23, 2012 by Mark Chataway Leave a Comment

Every year, Mark Chataway (of Hyderus) writes a piece for Pharmaceutical Executive. This year's piece is on how badly the pharmaceutical industry does with social media (and is co-written with James Ward). It's already proving highly controversial. "Pharma wants to play the role of a second-grade consumer marketer, not that of a thoughtful … [Read more...] about Pharmas intimacy problem with social media

Filed Under: Featured Tagged With: Global Health Progress, KONY 2012, Passiton, Pharmaceutical Executive, pharmaceutical industry, Robin Hood Tax, social media, Swabhimaan

Primary Sidebar

Categories

  • Featured (206)
  • Our craft (22)
  • Staff blog (56)
access to medicines Africa Chris Nial climate change communications consultancy coronavirus COVID-19 Development Donald Trump environment foreign policy Global Health Progress global warming green energy health healthcare health policy HIV Hyderus india Mark Chataway ODA PandemiCast patents pharmaceutical industry public health vaccination vaccines wales WHO

Hyderus on Twitter

Tweets by Hyderus

Hyderus on Facebook

Videos

The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
More videos

Clients

 
 
 

Footer

Looking For?

  • Our World
  • Contact us
  • Privacy Policy
  • Terms of use

Recent Posts

  • Accessible healthcare could aid climate crisis in rainforest communities
  • Climate change impact has the potential to regress cancer progress through healthcare disruption, according to study
  • Vaccines and COVID-19: Frans van den Boom speaks to Hyderus and Baird’s CMC

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Copyright © 2021 Hyderus. All rights reserved. Sitemap

  • Home
  • Tell the Truth
    ▼
    • Videos
  • About us
    ▼
    • Access to innovative medicines
    • New Work in India
    • Mark Chataway
    • We pay our taxes
    • Our approach to managing risk perception and crises
    • African journalists we respect
  • Customers
  • Expertise
    ▼
    • Development and Politics
      ▼
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      ▼
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      ▼
      • Drivers and barriers for new vaccines
    • Strategic Planning
      ▼
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      ▼
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Contact
  • Blog
    ▼
    • What we’re thinking
    • Our World
    • Staff blog
  • Flexible Pricing Plan

Cookies

This site uses cookies: Find out more.